ILife Discoveries Introduces an Innovative Gene Test in India to Evaluate Cancer Recurrence risk & assist clinicians make an informed treatment decisions
MammaPrint Test helps evaluate the risk of distant recurrence of breast cancer, and aids oncologists in identifying patients who can safely forego chemotherapy Oncologists across world today are increasingly relying on genomic tests like Blueprint to tailor treatments for different to patients by knowing more about the tumor’s biology New Delhi, May 27, 2015: Adding …